Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging
This unified, single-point-of-contact approach brings significant production benefits to pharma partners through minimising the number of friction points that can be present in a more fragmented supply chain and ensuring that all components ultimately knit together into a coherent combination product
It's not a matter of 'if,' but 'when' and 'how fast.' And what you reconstitute it with is arguably the most important decision you'll make
Simple habits, like eating more fruits and vegetables, avoiding sugary drinks, and planning meals, can support healthy weight loss
.webp)
